January 1, 2018Analytical validation of a next-generation sequencing assay to monitor immune responses in solid tumors Read more »
September 1, 2019Chemokine expression signatures in infiltrated vs non-infiltrated tumors Read more »
January 19, 2019Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing Read more »
May 9, 2018Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden Read more »
July 1, 2018Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors Read more »
May 29, 2018PD-L2 amplification and durable disease stabilization in patient with urothelial carcinoma receiving pembrolizumab Read more »
